Hans Nienhuis

Statistics

Publications

Citations

872

H-Index

Active since

2007

Affiliations

University Medical Center Groningen(Current)

University of Groningen

Pfizer (United States)

Umeå University

Assistance Publique – Hôpitaux de Paris

Hans Nienhuis is an author at University Medical Center Groningen specializing in hereditary amyloidosis, medicine, and wild-type transthyretin amyloidosis.

ORCID

Publications per year

2007–2025

Publications

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update

Angela Dispenzieri, Teresa Coelho, Isabel Conceição et al. · Orphanet Journal of Rare Diseases · 2022 · 89 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis

Angelo Giuseppe Caponetti, Claudio Rapezzi, Christian Gagliardi et al. · JACC Heart Failure · 2021 · 76 citations · Full text

Medicine, Cardiology, Genetics +14

Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey

José Nativi-Nicolau, Alfonso Siu, Angela Dispenzieri et al. · JACC CardioOncology · 2021 · 61 citations · Full text

Medicine, Cardiology, Pathology +14

Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts

Hans Nienhuis, Karina de Leeuw, J. Bijzet et al. · Lara D. Veeken · 2008 · 56 citations · Full text

Life Sciences, Immunology, Pathobiology +17

1–5 of 22